Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.

[1]  Ding‐Shinn Chen,et al.  Association of pre‐S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.

[2]  Y. Liaw,et al.  Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma , 2007, Gut.

[3]  M. Yuen,et al.  Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels , 2007, Gut.

[4]  J. Kao,et al.  Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma. , 2006, World journal of gastroenterology.

[5]  Ding‐Shinn Chen,et al.  Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. , 2006, The Journal of infectious diseases.

[6]  S. Sarin,et al.  Basal core promoter, precore region mutations of HBV and their association with e antigen, genotype, and severity of liver disease in patients with chronic hepatitis B in India , 2006, Journal of medical virology.

[7]  Ding-Shinn Chen,et al.  Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. , 2006, The Journal of infectious diseases.

[8]  Guan-Tarn Huang,et al.  Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. , 2006, JAMA.

[9]  M. Yuen,et al.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications , 2005, Gut.

[10]  V. Wong,et al.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma , 2004, Gut.

[11]  Ching-Lung Lai,et al.  Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: a case control study. , 2004, Carcinogenesis.

[12]  M. Yuen,et al.  Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. , 2004, Journal of hepatology.

[13]  M. Yuen,et al.  Real-time quantification of hepatitis B virus core-promoter and pre-core mutants during hepatitis E antigen seroconversion. , 2004, Journal of hepatology.

[14]  M. Mizokami,et al.  Hepatitis B Virus Genotypes and Hepatocellular Carcinoma in Japan , 2003, Intervirology.

[15]  J. Kalbfleisch,et al.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.

[16]  Eric R. Ziegel,et al.  The Elements of Statistical Learning , 2003, Technometrics.

[17]  F. Sugauchi,et al.  Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. , 2003, Gastroenterology.

[18]  Chee-Kin Hui,et al.  Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis‐related complications, and hepatocellular carcinoma , 2003, Hepatology.

[19]  Ding‐Shinn Chen,et al.  Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. , 2003, Gastroenterology.

[20]  Makoto Arai,et al.  Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease , 2003, Hepatology.

[21]  M. Mizokami,et al.  Preponderance of hepatitis B virus genotype B contributes to a better prognosis of chronic HBV infection in Okinawa, Japan , 2002, Journal of medical virology.

[22]  Chien-Jen Chen,et al.  Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.

[23]  A. Tsubota,et al.  Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw , 2001, Journal of medical virology.

[24]  T. Okanoue,et al.  A case‐control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C , 2001, Hepatology.

[25]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[26]  I. Lauder,et al.  Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience , 2000, Hepatology.

[27]  M. Baptista,et al.  High prevalence of 1762T 1764A mutations in the basic core promoter of hepatitis B virus isolated from black africans with hepatocellular carcinoma compared with asymptomatic carriers , 1999, Hepatology.

[28]  Ding‐Shinn Chen,et al.  Hepatitis B Virus Infection , 2007 .

[29]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.

[30]  R. Michael.  B Virus Infection , 1966 .

[31]  P. Loehrer,et al.  Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level , 2007 .

[32]  M. Sherman.  Hepatocellular carcinoma: epidemiology, risk factors, and screening. , 2005, Seminars in liver disease.

[33]  E. Schiff,et al.  Histological outcome during long-term lamivudine therapy. , 2003, Gastroenterology.